Decision Support for Lower Respiratory Infections in Children
(ROADS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on reducing inappropriate antibiotic use in children with lower respiratory tract infections (LRTI) such as pneumonia or bronchiolitis. The study tests two new tools, ED Clinical Decision Support (CDS-ED) and Transitions Clinical Decision Support (CDS-Tr), designed to assist doctors in emergency departments and hospitals in making informed decisions about antibiotic use. Researchers compare these tools against usual care to evaluate their effectiveness. Children visiting the emergency room or admitted to the hospital with symptoms like a cough or shortness of breath may be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to contribute to important research that could enhance antibiotic use in children.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on reducing inappropriate antibiotic use for certain infections in children.
What prior data suggests that these clinical decision support tools are safe for use in pediatric emergency and inpatient settings?
Research has shown that clinical decision support (CDS) systems can help reduce unnecessary antibiotic use for respiratory infections. This is important because antibiotics can cause side effects, especially when not needed. CDS technology is generally well-accepted because it aids doctors in making better decisions rather than introducing a new drug or treatment.
Studies on similar CDS tools have demonstrated their effectiveness in hospitals. They help medical staff adhere more closely to guidelines, resulting in fewer unnecessary antibiotics. This enhances safety by reducing the risk of antibiotic side effects. While no direct human trial data exists for this specific CDS tool, similar tools have proven to be safe.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential of clinical decision support tools to improve care for children with lower respiratory infections. Unlike standard treatments that rely solely on the clinician's judgment and experience, these tools provide real-time, evidence-based guidance tailored to specific clinical settings. The ED Clinical Decision Support (CDS-ED) and Transitions Clinical Decision Support (CDS-Tr) tools aim to enhance decision-making in emergency and inpatient settings, respectively. By integrating these tools, the study hopes to optimize treatment plans, improve patient outcomes, and potentially streamline healthcare processes.
What evidence suggests that these clinical decision support tools are effective for reducing inappropriate antibiotic use in pediatric lower respiratory infections?
Research has shown that clinical decision support (CDS) systems can significantly reduce unnecessary antibiotic prescriptions for respiratory infections. One study suggested that these tools help doctors use antibiotics more appropriately for respiratory tract infections. In this trial, emergency room doctors will use the CDS-ED tool to improve antibiotic decision-making. Meanwhile, hospital doctors will use the CDS-Tr tool to ensure treatments align with the latest guidelines. Both tools, part of separate treatment arms in this trial, aim to address the issue of overprescribing antibiotics, which can lead to unwanted side effects and antibiotic resistance. These interventions have shown promise in aligning treatments with recommended practices.13678
Who Is on the Research Team?
Derek J Williams, MD, MPH
Principal Investigator
Vanderbilt University Medical Center
Are You a Good Fit for This Trial?
This trial is for children visiting the emergency department (ED) with lower respiratory tract infections like pneumonia, bronchiolitis, or asthma-related infections. It aims to reduce unnecessary antibiotic use in these patients.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive clinical decision support interventions in the ED and hospital settings to reduce inappropriate antibiotic use
Follow-up
Participants are monitored for safety and effectiveness after treatment, including antibiotic exposure and clinical outcomes
Extension
Long-term monitoring of antibiotic use and clinical outcomes
What Are the Treatments Tested in This Trial?
Interventions
- ED Clinical Decision Support (CDS-ED)
- Transitions Clinical Decision Support (CDS-Tr)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University Medical Center
Lead Sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator
University of California, San Francisco
Collaborator